NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $16.4 million in its third quarter.
The Newark, California-based company said it had a loss of 61 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
The biopharmaceutical company posted revenue of $4.1 million in the period.
Protagonist Therapeutics shares have risen 72% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $11.60, a rise of 33% in the last 12 months.